BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 376387)

  • 1. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
    Gandola L; Pozzi E; Tansini G
    G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
    Hoefer H; Scheef W; Titscher R; Kokron O
    Osterr Z Onkol; 1974; (1):3-7. PubMed ID: 4619650
    [No Abstract]   [Full Text] [Related]  

  • 3. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 4. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
    McNiel NO; Morgan LR
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
    Kokron O
    Osterr Z Onkol; 1974; (5-6):123-7. PubMed ID: 4377798
    [No Abstract]   [Full Text] [Related]  

  • 6. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
    Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
    Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
    [No Abstract]   [Full Text] [Related]  

  • 7. Ifosfamide and Mesna in advanced malignancies.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with the cytostatic drug ifosfamide].
    Ritter S; Schröder HJ
    Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
    Seccia A; Scafuri L; Scognamillo A; Cocco G
    G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 12. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug found active against lung cancers.
    Hospitals; 1982 Jun; 56(12):38. PubMed ID: 7042515
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
    Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L
    Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
    Chiuten DF; Carr DT; Dhingra HM; Murphy WK; Spitzer G; Umsawasdi T; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1986 Jun; 70(6):795-6. PubMed ID: 3015403
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Matthiessen W; Stempinski E; Göbel D; Thalmann U
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of response to ifosfamide in squamous cell bronchogenic carcinoma.
    Banks J; Anderson EG; Smith AP
    Cancer Chemother Pharmacol; 1989; 23(2):128. PubMed ID: 2910511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide].
    Kochnowski G; Rozek G; Wisńiewski J
    Wiad Lek; 1976 Feb; 29(4):270-1. PubMed ID: 1251645
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
    Saiers JH; Slavik M
    Vet Hum Toxicol; 1981; 23(Suppl 1):12-4. PubMed ID: 6272470
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.